Are we better in treating hormone-responsive metastatic breast cancer in 2020?- Role of CDK 4/6 among the classical hormonal interventions (BC_REF)


E-session 587010

Expert
Olivia Pagani'
Riviera-Chablais Hospital
Rennaz, Switzerland

24
Sep 2021